Episode Details

In this episode, Prof. Konstantin Slavin reads aloud an article by Garston Liang, Quentin F. Gronau, and Alexander Thorpe which addresses the use of N-of-1 trials in neuromodulation and personalized medicine. N-of-1 trials are a powerful method for investigating treatment effects on an individual basis, making them ideal for patients with stable symptoms and chronic disorders.Key points covered include:- N-of-1 Trial Design: Involves repeated cycles of treatment and placebo, with the patient serving as their own control.- Personalization: Tailors treatment decisions to individual outcomes, offering a high level of evidence for treatment efficacy.- Double-Blinding: Ensures both patient and clinician are unaware of the treatment phase to maintain objectivity.- Crossover Design: Alternates between treatment and placebo phases, often randomized to prevent time-related biases.- Wash-In/Out Periods: Important for avoiding carry-over effects, especially in pharmaceutical interventions.The article also highlights the statistical considerations for analyzing N-of-1 trials, emphasizing the importance of proper design and analysis to ensure valid conclusions. Tune in to learn how N-of-1 trials can enhance personalized treatment strategies in neuromodulation and beyond.

Resources:

1. Biostatistics articles on the INS website
2. N-of-1 Trials & Their Use in Neuromodulation